Home | Welcome to Contract Pharma   
Last Updated Friday, August 29 2014
Print

Search Results for 'biopharma companies'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

2012 Top 10 Biopharma Companies
Published July 19, 2012
Our annual look at the 10 biggest players in the Biopharmaceutical marketplace Read More »
Top 10 Biopharma Companies
By Gil Y. Roth, Editor
Published July 18, 2012
Our annual look at the 10 biggest players in the Biopharmaceutical marketplace Read More »
The Top 10 Biopharmaceutical Companies
By Gil Y. Roth
Published July 14, 2011
Our annual look at the 10 biggest biopharmaceutical players Read More »
The Top 20 Pharmaceutical Companies
By Gil Y. Roth
Published July 14, 2011
Our annual look at the biggest companies in the pharma industry Read More »
2010 Top 10 Biopharmaceutical Companies Report
By Gil Roth
Published July 9, 2010
Our rules for inclusion on the Top 10 Biopharma list are as follows: you’re a biopharma company if more than half of your drug revenues — not royalties — come from large-molecule drugs and vaccines. It’s arbitrary, but it&rs… Read More »
2009 Top 20 Pharmaceutical Companies Report
Published July 15, 2009
They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top! Read More »
2008 Top 20 Pharmaceutical Companies Report
Published July 18, 2008
The weak U.S. dollar played a strong role in this year’s Top 20 Pharma Report. Several overseas players look a lot better than they should, thanks to my insistence on converting all results to dollars. In local currencies, many foreign and domestic players were barely able to eke out growth in 2007. Read More »
Will Cell-Based Therapy Shape Biopharma’s Future?
Published June 3, 2014
Pluristem’s CEO, Zami Aberman, compares the state of stem cell research today to where antibodies were 20 years ago. Clinical evidence is key to moving the technology forward, he says. Read More »
CRO Outlook & Opportunities
By Kristin Brooks, Contract Pharma
Published May 30, 2012
e-Clinical solutions fuel advances Read More »
By Steve Snyder
Published November 14, 2011
How the drug development industry has changed over the years. Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On